Butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate
CAS No.:
Cat. No.: SC251035
Available on Request
Price on Request
Contact us for pricing, MOQ, and lead time
Product Name :Butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate
Cat. No.: :SC251035
Purity / Specification :—
CAS No. :477775-14-7
MDL No. :—
Molecular Formula :C23H29N3O4S2
LogP :5.30
Molecular Weight :475.62
TPSA :127.0
Category :API Impurities
HSN Code :—
SMILES Code :CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C=CN=C3
Melting Point :—
InChI Key : :XTEOJPUYZWEXFI-UHFFFAOYSA-N
Boiling Point :No data available
Application Note
AI GeneratedGenerated by AI. Verify before use in regulatory documents.
Lipinski & ADMET Properties
Computational estimateLipinski Rule of 5
iMW ≤ 500 Da✓ 475.6 Da
LogP ≤ 5✗ 5.30
HBD ≤ 5✓ 1
HBA ≤ 10✓ 6
Max 1 violation allowed for oral bioavailability.
Drug-likeness Score
i42/100
Fragment / low drug-likeness
Predicted LogP
i5.30log units
Highly lipophilic
CNS Permeability
iClark model · J Pharm Sci, 1999
CNS− unlikely
TPSA 127.0Ų · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−
Requires experimental confirmation.
⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.
